Re-patterning of H3K27me3, H3K4me3 and DNA methylation during fibroblast conversion into induced cardiomyocytes

Stem Cell Research

Volumn 16, Issue 2, 2016, Pages 507-518

  Liu, Ziqing ^a,b   Chen, Olivia ^a,b   Zheng, Michael ^a,b   Wang, Li ^a,b   Zhou, Yang ^a,b   Yin, Chaoying ^a,b   Liu, Jiandong ^a,b   Qian, Li ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

ChIP; DNA methylation; Epigenetics; H3K27me3; H3K4me3; ICM; Reprogramming

Indexed keywords

HISTONE; HISTONE H3K27ME3; HISTONE H3K4ME3; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; MESSENGER RNA; TRANSCRIPTION FACTOR SOX9; TWIST RELATED PROTEIN 1; TWIST RELATED PROTEIN 2;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL ISOLATION; CHROMATIN; COMPARATIVE STUDY; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; FLOW CYTOMETRY; GENE EXPRESSION; GENE REGULATORY NETWORK; HEART FIBROBLAST; HEART MUSCLE CELL; HISTONE DEMETHYLATION; IMMUNOFLUORESCENCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MARKER GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; ANIMAL; CARDIAC MUSCLE CELL; CELL LINE; CYTOLOGY; FIBROBLAST; FLUORESCENCE MICROSCOPY; GENETIC EPIGENESIS; GENETICS; METABOLISM; NUCLEAR REPROGRAMMING; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

ANIMALS; CELL LINE; CELLULAR REPROGRAMMING; DNA METHYLATION; EPIGENESIS, GENETIC; FIBROBLASTS; FLOW CYTOMETRY; HISTONES; MICE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; MYOCYTES, CARDIAC; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOX9 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TWIST-RELATED PROTEIN 1; TWIST-RELATED PROTEIN 2;

EID: 84959276987     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2016.02.037     Document Type: Article

References (67)

1. Acharya A., Baek S.T., Huang G., et al. The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 2012, 139:2139-2149.
2. Addis R.C., Ifkovits J.L., Pinto F., et al. Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success. J. Mol. Cell. Cardiol. 2013, 60:97-106.
3. Baum J., Duffy H.S. Fibroblasts and myofibroblasts: what are we talking about?. J. Cardiovasc. Pharmacol. 2011, 57:376-379.
4. Bernstein B.E., Meissner A., Lander E.S. The mammalian epigenome. Cell 2007, 128:669-681.
5. Bernstein B.E., Mikkelsen T.S., Xie X., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125:315-326.
6. Bhattacharyya S., Wu M., Fang F., et al. Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy. Matrix Biol. 2011, 30:235-242.
7. Boyer L.A., Plath K., Zeitlinger J., et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 2006, 441:349-353.
8. Braitsch C.M., Combs M.D., Quaggin S.E., et al. Pod1/Tcf21 is regulated by retinoic acid signaling and inhibits differentiation of epicardium-derived cells into smooth muscle in the developing heart. Dev. Biol. 2012, 368:345-357.
9. Buganim Y., Faddah D.A., Jaenisch R. Mechanisms and models of somatic cell reprogramming. Nat. Rev. Genet. 2013, 14:427-439.
10. Christoforou N., Chellappan M., Adler A.F., et al. Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming. PLoS One 2013, 8:e63577.
11. Delgado-Olguin P., Huang Y., Li X., et al. Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis. Nat. Genet. 2012, 44:343-347.
12. Fang F., Ooka K., Bhattacharyya S., et al. The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-beta that is up-regulated in systemic sclerosis and mediates profibrotic responses. Am. J. Pathol. 2011, 178:2077-2090.
13. Fang F., Shangguan A.J., Kelly K., et al. Early growth response 3 (Egr-3) is induced by transforming growth factor-beta and regulates fibrogenic responses. Am. J. Pathol. 2013, 183:1197-1208.
14. Feldman N., Gerson A., Fang J., et al. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat. Cell Biol. 2006, 8:188-194.
15. Gilsbach R., Preissl S., Gruning B.A., et al. Dynamic DNA methylation orchestrates cardiomyocyte development, maturation and disease. Nat. Commun. 2014, 5:5288.
16. Giudice J., Xia Z., Wang E.T., et al. Alternative splicing regulates vesicular trafficking genes in cardiomyocytes during postnatal heart development. Nat. Commun. 2014, 5:3603.
17. Hamalainen E.R., Jones T.A., Sheer D., et al. Molecular cloning of human lysyl oxidase and assignment of the gene to chromosome 5q23.3-31.2. Genomics 1991, 11:508-516.
18. He A., Ma Q., Cao J., et al. Polycomb repressive complex 2 regulates normal development of the mouse heart. Circ. Res. 2012, 110:406-415.
19. He A., Shen X., Ma Q., et al. PRC2 directly methylates GATA4 and represses its transcriptional activity. Genes Dev. 2012, 26:37-42.
20. Hirai H., Katoku-Kikyo N., Keirstead S.A., et al. Accelerated direct reprogramming of fibroblasts into cardiomyocyte-like cells with the MyoD transactivation domain. Cardiovasc. Res. 2013, 100:105-113.
21. Huang P., He Z., Ji S., et al. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature 2011, 475:386-389.
22. Hussein S.M., Puri M.C., Tonge P.D., et al. Genome-wide characterization of the routes to pluripotency. Nature 2014, 516:198-206.
23. Ieda M., Fu J.D., Delgado-Olguin P., et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010, 142:375-386.
24. Ifkovits J.L., Addis R.C., Epstein J.A., et al. Inhibition of TGFbeta signaling increases direct conversion of fibroblasts to induced cardiomyocytes. PLoS One 2014, 9:e89678.
25. Inagawa K., Miyamoto K., Yamakawa H., et al. Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5. Circ. Res. 2012, 111:1147-1156.
26. Jackson M., Krassowska A., Gilbert N., et al. Severe global DNA hypomethylation blocks differentiation and induces histone hyperacetylation in embryonic stem cells. Mol. Cell. Biol. 2004, 24:8862-8871.
27. Jayawardena T.M., Egemnazarov B., Finch E.A., et al. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ. Res. 2012, 110:1465-1473.
28. Jozefczuk J., Drews K., Adjaye J. Preparation of mouse embryonic fibroblast cells suitable for culturing human embryonic and induced pluripotent stem cells. J. Vis. Exp. 2012, 64:e3854.
29. Koche R.P., Smith Z.D., Adli M., et al. Reprogramming factor expression initiates widespread targeted chromatin remodeling. Cell Stem Cell 2011, 8:96-105.
30. Kong P., Christia P., Saxena A., et al. Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis. Am. J. Physiol. Heart Circ. Physiol. 2013, 305:H1363-H1372.
31. Krenning G., Zeisberg E.M., Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis. J. Cell. Physiol. 2010, 225:631-637.
32. Lajiness J.D., Conway S.J. Origin, development, and differentiation of cardiac fibroblasts. J. Mol. Cell. Cardiol. 2014, 70:2-8.
33. Lee T.I., Jenner R.G., Boyer L.A., et al. Control of developmental regulators by polycomb in human embryonic stem cells. Cell 2006, 125:301-313.
34. Mansour A.A., Gafni O., Weinberger L., et al. The H3K27 demethylase utx regulates somatic and germ cell epigenetic reprogramming. Nature 2012, 488:409-413.
35. Mathison M., Gersch R.P., Nasser A., et al. In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor. J. Am. Heart Assoc. 2012, 1:e005652.
36. Mikkelsen T.S., Ku M., Jaffe D.B., et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007, 448:553-560.
37. Moore-Morris T., Guimaraes-Camboa N., Banerjee I., et al. Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. J. Clin. Invest. 2014, 124:2921-2934.
38. Muraoka N., Yamakawa H., Miyamoto K., et al. MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures. EMBO J. 2014, 33:1565-1581.
39. Nam Y.J., Lubczyk C., Bhakta M., et al. Induction of diverse cardiac cell types by reprogramming fibroblasts with cardiac transcription factors. Development 2014, 141:4267-4278.
40. Ng S.B., Bigham A.W., Buckingham K.J., et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat. Genet. 2010, 42:790-793.
41. Paige S.L., Thomas S., Stoick-Cooper C.L., et al. A temporal chromatin signature in human embryonic stem cells identifies regulators of cardiac development. Cell 2012, 151:221-232.
42. Papp B., Plath K. Epigenetics of reprogramming to induced pluripotency. Cell 2013, 152:1324-1343.
43. Polo J.M., Anderssen E., Walsh R.M., et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 2012, 151:1617-1632.
44. Protze S., Khattak S., Poulet C., et al. A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. J. Mol. Cell. Cardiol. 2012, 53:323-332.
45. Qian L., Berry E.C., Fu J.D., et al. Reprogramming of mouse fibroblasts into cardiomyocyte-like cells in vitro. Nat. Protoc. 2013, 8:1204-1215.
46. Qian L., Huang Y., Spencer C.I., et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012, 485:593-598.
47. Reddington J.P., Perricone S.M., Nestor C.E., et al. Redistribution of H3K27me3 upon DNA hypomethylation results in de-repression of polycomb target genes. Genome Biol. 2013, 14:R25.
48. Rodemann H.P., Rennekampff H. Functional diversity of fibroblasts. Tumor-Associated Fibroblasts and Their Matrix 2011, 23-36. M.M. Mueller, N.E. Fusenig (Eds.).
49. Sakai D., Suzuki T., Osumi N., et al. Cooperative action of Sox9, Snail2 and PKA signaling in early neural crest development. Development 2006, 133:1323-1333.
50. Smith C.L., Baek S.T., Sung C.Y., et al. Epicardial-derived cell epithelial-to-mesenchymal transition and fate specification require PDGF receptor signaling. Circ. Res. 2011, 108:e15-e26.
51. Snider P., Standley K.N., Wang J., et al. Origin of cardiac fibroblasts and the role of periostin. Circ. Res. 2009, 105:934-947.
52. Song K., Nam Y.J., Luo X., et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012, 485:599-604.
53. Sorrell J.M., Baber M.A., Caplan A.I. Site-matched papillary and reticular human dermal fibroblasts differ in their release of specific growth factors/cytokines and in their interaction with keratinocytes. J. Cell. Physiol. 2004, 200:134-145.
54. Suzuki M.M., Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 2008, 9:465-476.
55. Szabo E., Rampalli S., Risueno R.M., et al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010, 468:521-526.
56. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
57. Theunissen T.W., Jaenisch R. Molecular control of induced pluripotency. Cell Stem Cell 2014, 14:720-734.
58. Thiery J.P., Acloque H., Huang R.Y., et al. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
59. Vallaster M., Vallaster C.D., Wu S.M. Epigenetic mechanisms in cardiac development and disease. Acta Biochim. Biophys. Sin. 2012, 44:92-102.
60. Vierbuchen T., Ostermeier A., Pang Z.P., et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463:1035-1041.
61. Wamstad J.A., Alexander J.M., Truty R.M., et al. Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell 2012, 151:206-220.
62. Wang G.G., Song J., Wang Z., et al. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature 2009, 459:847-851.
63. Wang L., Liu Z., Yin C., et al. Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming. Circ. Res. 2015, 116:237-244.
64. Zhang C.L., McKinsey T.A., Chang S., et al. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 2002, 110:479-488.
65. Zhao Y., Londono P., Cao Y., et al. High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling. Nat. Commun. 2015, 6:8243.
66. Zhou H., Dickson M.E., Kim M.S., et al. Akt1/protein kinase B enhances transcriptional reprogramming of fibroblasts to functional cardiomyocytes. Proc. Natl. Acad. Sci. U. S. A. 2015, 112:11864-11869.
67. Zhou V.W., Goren A., Bernstein B.E. Charting histone modifications and the functional organization of mammalian genomes. Nat. Rev. Genet. 2011, 12:7-18.